Sino Biopharmaceutical | 1177 - Operating Expenses

Stock Price
5.39
Daily Change
-0.20 -3.58%
Monthly
-11.78%
Yearly
33.09%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY12.39B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Ionis Pharmaceuticals USD 364M 54M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Moderna USD 1.78B 242M Mar/2026
Organon & Co USD 903M 387M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.54B 323.9M Mar/2026
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025